My Medication Side Effects Are Too Popular

Later, Xinming Pharmaceutical greeted those hospitals, and either made it clear to the other party when prescribing the medicine, and told them the consequences of not taking the medicine according to the instructions.

Or choose to blame the hospital, let the doctor give medicine, wash, and avoid the result that the hair in other parts also becomes thick

As for some hospitals taking the opportunity to prescribe more nutritional medicines, he really has no control for the time being.

Fortunately, most people are still very satisfied with the effect, which brings a lot of energy points to Fu Liang.

Grade: LV9a

Host: Fu Liang.

Energy: 487945 points (increased to 512000 points, allowing system upgrades)

Magnification: 0~2560.

Number of magnifying side effects: 256

With a multiple of more than [-] times and more than [-] energy points, Fu Liang has never felt so rich.

He took the computer out of the safe and started looking through the prescriptions.

This medicine for hepatitis has good side effects, lower blood pressure, lower urine protein

The probability of occurrence is only [-]%?

Two months ago, Fu Liang could only stare at this side effect, and there was nothing he could do.

But now, isn't it just a thousand times magnification, whole!

[The host specifies to amplify the drug's side effects of lowering blood pressure and reducing urine protein by 1000 times, is it certain?]

"Sure"! "

[The host consumes 200000 energy points to amplify the drug's low blood pressure and low urine egg self-side effects by 1000 times. ]

[The fine-tuning formula of the drug has been generated, and the side effects of lowering blood pressure and lowering urinary protein are expected to be ultra-high incidence side effects, and the probability of occurrence of these side effects reaches 99.9

9%!

[Please let the host use the medicine to more people as soon as possible. According to the feedback from the user, a large number of energy points can be obtained. 】

-A new drug for quick-acting blood pressure lowering has appeared.

The world's best-selling quick-acting blood pressure lowering drug was Huoluoxi, one of Pfizer's well-known drugs.

At present, the most commonly used antihypertensive drugs are mainly sartan and dipine antihypertensive drugs, among which Huoluoxi is the representative of dipine.

When most people choose drugs, they will choose big pharmaceutical companies. They feel that the technology of big pharmaceutical companies is better and the effect is better, unless the price gap is too large.

Just like Sildenafil, the effect of Jin Ge is slightly worse than Viagra.

This one developed by Fu Gao is not the common antihypertensive drugs mentioned above, but the antihypertensive effect is even better.

Dipines are fast and long-acting. It does not matter if the patient occasionally misses a dose, but it has a relatively large burden on the kidneys.

Sartans have fewer side effects, but they metabolize quickly, so they cannot be missed, and their blood pressure is slower than that of dipines. They are mainly used for long-term use to control blood pressure.

Fu Liang's new drug can rapidly increase pressure, can control blood pressure stably for a long time, and has far fewer side effects than those common pressure medicines.

Therefore, it will not only replace dipine antihypertensive drugs such as Huoluoxi, but also replace sartan antihypertensive drugs, becoming the first choice for all patients!

Seeing that there are still many energy points left, Fu Liang aimed at a detumescence drug.

The side effects of inhibiting the synthesis of Yin Yin are amplified, the side effects of antibacterial and antiviral are amplified, and a new anti-inflammatory drug is formed.

Especially for arthritis, spondylitis, etc. have a particularly good effect.

Many people think that the side effects of drugs must be bad effects.

, in fact, side effects refer to pharmacological effects other than the main therapeutic effect.

Just like Viagra, the effect that many men rave about is actually a side effect.

The emergence of many new drugs is that some side effects have been discovered, amplified, and become a new treatment direction.

The two new drugs in a row also almost exhausted Fu Liang's energy points.

But he is very happy, the market prospects of these two drugs are very broad

, and coincidentally, against Pfizer.

The number of people with high blood pressure in the world is also close to one-sixth.

It means that more than one billion people in the world suffer from high blood pressure, so there are so many antihypertensive drugs.

Pharmaceutical company R&D and production

Fu Gao believes that this new antihypertensive drug will once again cause shocks in the global antihypertensive drug market.

As long as the price is not particularly high, it can sweep the market in a few years.

It is impossible to directly occupy the market (good money and good), after all, many antihypertensive drugs have a history of more than ten years or even decades.

In the minds of patients, it is safer to eat.

After all, antihypertensive drugs need to be taken for a long time, even without interruption

This anti-inflammatory drug for the treatment of rheumatoid arthritis and spondylitis will not sweep the market in a short time.

But it is no problem to grab a market share and gradually erode the market of other pharmaceutical companies.

Considering that even though many drugs have good curative effects, many similar products on the market have good curative effects, and the safety is worthy of reassurance for patients.

Time to start making a detailed plan for drug development

After three or five years like this, the special drug he developed will become the mainstream drug in the market, and no pharmaceutical company will be able to compete with him anymore.

Just as he was making plans, Pfizer's chairman, Eberle, called

PS: Ask for flowers, ask for evaluation, ask for automatic subscription! ! !

Rear

Chapter [-]: Pfizer was soft and forced to transform

"Xiao Fu Xianniu, I'm Able, the chairman of Pfizer. I took the liberty to call you, didn't I bother you with your research?

Abel's tone was very polite, he was afraid of angering the young man.

Young people act impulsive,

They don't want to bear it at all, but the other party still has the ability to retaliate against them Pfizer, which makes them have to surrender

Fu Liang leaned on the back of the chair, and the chair turned in a different direction: "What's the matter? You and I, Pfizer, don't seem to have any place to cooperate, and the future looks

There seems to be no place for cooperation.

Fu Liang couldn't see the failure of Pfizer's cooperation, so he turned his head and stumbled his peers.

Peers are not necessarily enemies, they can also cooperate

Didn't Pfizer cooperate with many peers to develop some best-selling drugs.

Big companies behave in a more domineering style, and Fu Liang also understands it.

But if it is overbearing to him, it will not work!

Abel sighed, it seemed that Fu Liang's grievances had not been fully vented.

"Mr. Xiaofu, we may not have a place where we can cooperate.

"We have many new drug projects that have stopped research and development. I heard that Mr. Xiaofu is very interested in this kind of prescription?

Fu Gao's heart moved, it seems that many people have noticed this, but so what?

Those people can develop their own research and development, can they succeed in research and development?

Li Baile didn't hear Fu Liang's rebuttal, and knew that he had made the right bet this time.

The directors of the company discussed how to reconcile with Xinming Pharmaceutical, and stop fighting like this.

Those Yu Rong companies have finally been scattered, and the stocks of pharmaceutical companies have finally stopped falling.

But it's not that easy to get back up again.

Without major benefits, who would buy it?

Pfizer's profits are all used to repurchase its own shares. Where is the stock dividend at the end of the year?

On the contrary, many people are waiting for Xinming Pharmaceutical to go on the market, even if there are no other drugs to be developed.

, the profit of each new drug in the future will definitely start from tens of billions of dollars!

Female Bole was worried that Fu Gaozhen would soon develop some anti-inflammatory drugs, or antihypertensive drugs, which would be a huge blow to Pfizer.

Pfizer has fallen from the first to tenth in market value of pharmaceutical companies, and if it falls further, I am afraid it will fall out of the top ten.

The number one pharmaceutical company is a golden sign. After all, many people are willing to choose big pharmaceutical companies when buying commonly used drugs.

even if there is no first

, the top ten is not bad

But after the top ten, that is another grade.

Aberle persuaded other shareholders and directors to settle with Xinming Pharmaceutical.

But how to reconcile is another question.

Fortunately, Williams reminded him that Johnson & Johnson obtained the cooperation with Xinming Pharmaceutical because of giving away some more discarded prescriptions during the negotiation.

Opportunity for a quick stop.

I heard that Xinming Pharmaceutical was also buying such semi-finished prescriptions in the East.

So Nv Bole made special preparations this time, and instead of calling Fu Xinming, she called Fu Liang directly.

"Mr. Xiao Fu, we at Pfizer are willing to put those new drug projects that the laboratory has stopped developing,